Market Expansion Opportunities Stallergenes Greer has a strong global presence with products available in over 40 countries, providing ample opportunity to expand partnerships and sales channels within existing markets or to explore new regions, especially in emerging markets seeking allergy immunotherapy solutions.

Product Acquisition Leverage Following their recent acquisition of Palforzia from Nestlé, there is potential to cross-sell related allergy immunotherapy products and services to existing customer bases, as well as to develop integrated marketing strategies around these high-profile assets.

Innovative Treatment Portfolio With a focus on allergen immunotherapy and precision medicine, Stallergenes Greer offers tailored allergy treatment solutions that can be scaled through partnerships, highlighting a growth opportunity in personalized allergy management solutions for healthcare providers.

Industry Leadership & Events Participation in prominent industry events such as EAACI 2025 demonstrates a commitment to innovation and thought leadership, presenting chances to engage with key opinion leaders, influencers, and potential clients invested in advanced allergy treatments.

Digital & Technology Adoption The company's use of advanced technology stacks like Salesforce and Pardot suggests readiness for digital marketing and CRM-driven sales approaches, enabling targeted outreach to healthcare providers and increasing conversion efficiency in allergy therapeutics markets.